PROMETIC COMPLETES THE FILING OF ITS PLASMINOGEN BIOLOGICS LICENSE APPLICATION (“BLA”) WITH THE U.S. FDA

April 5, 2017
Posted by: Fred Dumais
Posted In: Press Releases, Press Releases 2017
X